RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      KCI등재 SCOPUS

      Does Platelet-rich Plasma Augmentation Following Hip Arthroscopy Improve Outcomes: A Systematic Review

      한글로보기

      https://www.riss.kr/link?id=A106885716

      • 0

        상세조회
      • 0

        다운로드
      서지정보 열기
      • 내보내기
      • 내책장담기
      • 공유하기
      • 오류접수

      부가정보

      다국어 초록 (Multilingual Abstract)

      Platelet-rich plasma (PRP) has gathered widespread acceptance among orthopaedic surgeons because of its multimodal effects on tissue healing. Varying results have been reported when PRP injections are combined with hip arthroscopic surgery. To evaluat...

      Platelet-rich plasma (PRP) has gathered widespread acceptance among orthopaedic surgeons because of its multimodal effects on tissue healing. Varying results have been reported when PRP injections are combined with hip arthroscopic surgery. To evaluate the influence of PRP on clinical outcomes following hip arthroscopy. We hypothesized that patients treated with PRP would have improved postoperative outcome scores. A search of the National Institute for Health and Care Excellence (NICE) healthcare database advanced search (HDAS) via Athens (PubMed, MEDLINE, CINAHL, EMBASE, and AMED databases) was conducted from their years of inception to May 2018 with the keywords: “Hip Arthroscopy” and “Platelet-Rich Plasma”. A quality assessment was performed based on the Cochrane risk of bias tool. Three studies were included for analysis; two of which had low risk of bias. The studies included 363 hips, of which 141 were randomised for PRP treatment. The mean age of all patients was 35 years and the follow-up ranged from 18.5 to 36 months. Authors used different PRP systems and preparations. Modified Harris hip score was reported in all three studies with two studies favouring the use of PRP. The use of PRP following hip arthroscopy did not lead to significantly improved postoperative pain or functional outcomes when compared to control groups in the studies included in this review.

      더보기

      참고문헌 (Reference)

      1 McCarthy JC, "What factors influence long-term survivorship after hip arthroscopy?" 469 : 362-371, 2011

      2 Sánchez M, "Ultrasound-guided platelet-rich plasma injections for the treatment of osteoarthritis of the hip" 51 : 144-150, 2012

      3 Sengodan VC, "Treatment of partial rotator cuff tear with ultrasound-guided platelet-rich plasma" 7 : 32-, 2017

      4 Kraeutler MJ, "The use of platelet-rich plasma to augment conservative and surgical treatment of hip and pelvic disorders" 6 : 410-419, 2016

      5 Sun Y, "The regenerative effect of platelet-rich plasma on healing in large osteochondral defects" 34 : 589-597, 2010

      6 Vavken P, "The potential for primary repair of the ACL" 19 : 44-49, 2011

      7 LaFrance R, "The effect of platelet enriched plasma on clinical outcomes in patients with femoroacetabular impingement following arthroscopic labral repair and femoral neck osteoplasty" 2 : 158-163, 2015

      8 Zhou Y, "The differential effects of leukocyte-containing and pure platelet-rich plasma(PRP)on tendon stem/progenitor cells-implications of PRP application for the clinical treatment of tendon injuries" 6 : 173-, 2015

      9 Alsousou J, "The biology of platelet-rich plasma and its application in trauma and orthopaedic surgery : a review of the literature" 91 : 987-996, 2009

      10 Higgins JP, "The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials" 343 : d5928-, 2011

      1 McCarthy JC, "What factors influence long-term survivorship after hip arthroscopy?" 469 : 362-371, 2011

      2 Sánchez M, "Ultrasound-guided platelet-rich plasma injections for the treatment of osteoarthritis of the hip" 51 : 144-150, 2012

      3 Sengodan VC, "Treatment of partial rotator cuff tear with ultrasound-guided platelet-rich plasma" 7 : 32-, 2017

      4 Kraeutler MJ, "The use of platelet-rich plasma to augment conservative and surgical treatment of hip and pelvic disorders" 6 : 410-419, 2016

      5 Sun Y, "The regenerative effect of platelet-rich plasma on healing in large osteochondral defects" 34 : 589-597, 2010

      6 Vavken P, "The potential for primary repair of the ACL" 19 : 44-49, 2011

      7 LaFrance R, "The effect of platelet enriched plasma on clinical outcomes in patients with femoroacetabular impingement following arthroscopic labral repair and femoral neck osteoplasty" 2 : 158-163, 2015

      8 Zhou Y, "The differential effects of leukocyte-containing and pure platelet-rich plasma(PRP)on tendon stem/progenitor cells-implications of PRP application for the clinical treatment of tendon injuries" 6 : 173-, 2015

      9 Alsousou J, "The biology of platelet-rich plasma and its application in trauma and orthopaedic surgery : a review of the literature" 91 : 987-996, 2009

      10 Higgins JP, "The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials" 343 : d5928-, 2011

      11 Moher D, "Preferred reporting items for systematic reviews and metaanalyses:the PRISMA statement" 6 : e1000097-, 2009

      12 Mei-Dan O, "Platelet-rich plasma or hyaluronate in the management of osteochondral lesions of the talus" 40 : 534-541, 2012

      13 Rafols C, "Platelet-rich plasma augmentation of arthroscopic hip surgery for femoroacetabular impingement : a prospective study with 24-month follow-up" 31 : 1886-1892, 2015

      14 Zayni R, "Platelet-rich plasma as a treatment for chronic patellar tendinopathy : comparison of a single versus two consecutive injections" 5 : 92-98, 2015

      15 De Pascale MR, "Platelet derivatives in regenerative medicine : an update" 29 : 52-61, 2015

      16 Dhillon MS, "PRP in OA knee-update, current confusions and future options" 3 : 27-, 2017

      17 Yan R, "Intratendon delivery of leukocytepoor platelet-rich plasma improves healing compared with leukocyte-rich platelet-rich plasma in a rabbit achilles tendinopathy model" 45 : 1909-1920, 2017

      18 Freeman CR, "Hip preservation surgery : surgical care for femoroacetabular impingement and the possibility of preventing hip osteoarthritis" 1 : 46-55, 2014

      19 Higgins JPT, "Cochrane handbook for systematic reviews of interventions version 5.1.0"

      20 Redmond JM, "Clinical results of hip arthroscopy for labral tears : a comparison between intraoperative platelet-rich plasma and bupivacaine injection" 31 : 445-453, 2015

      21 Varshney A, "Autologous platelet-rich plasma versus corticosteroid in the management of elbow epicondylitis : a randomized study" 7 : 125-128, 2017

      22 Randelli PS, "Autologous platelet rich plasma for arthroscopic rotator cuff repair" 30 : 1584-1589, 2008

      23 Guadilla J, "Arthroscopic management and platelet-rich plasma therapy for avascular necrosis of the hip" 20 : 393-398, 2012

      더보기

      분석정보

      View

      상세정보조회

      0

      Usage

      원문다운로드

      0

      대출신청

      0

      복사신청

      0

      EDDS신청

      0

      동일 주제 내 활용도 TOP

      더보기

      주제

      연도별 연구동향

      연도별 활용동향

      연관논문

      연구자 네트워크맵

      공동연구자 (7)

      유사연구자 (20) 활용도상위20명

      인용정보 인용지수 설명보기

      학술지 이력

      학술지 이력
      연월일 이력구분 이력상세 등재구분
      2025 평가예정 해외DB학술지평가 신청대상 (해외등재 학술지 평가)
      2022-01-01 평가 등재학술지 유지 (해외등재 학술지 평가) KCI등재
      2019-01-01 평가 등재학술지 유지 (계속평가) KCI등재
      2016-01-01 평가 등재학술지 유지 (계속평가) KCI등재
      2012-06-29 학술지명변경 한글명 : 대한고관절학회지 -> Hip and Pelvis
      외국어명 : The Journal of Korean Hip Society -> Hip and Pelvis
      KCI등재
      2012-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2009-01-01 평가 등재학술지 선정 (등재후보2차) KCI등재
      2008-01-01 평가 등재후보 1차 PASS (등재후보1차) KCI등재후보
      2007-01-01 평가 등재후보 1차 FAIL (등재후보2차) KCI등재후보
      2006-01-01 평가 등재후보 1차 PASS (등재후보1차) KCI등재후보
      2004-01-01 평가 등재후보학술지 선정 (신규평가) KCI등재후보
      더보기

      학술지 인용정보

      학술지 인용정보
      기준연도 WOS-KCI 통합IF(2년) KCIF(2년) KCIF(3년)
      2016 0.04 0.04 0.04
      KCIF(4년) KCIF(5년) 중심성지수(3년) 즉시성지수
      0.05 0.05 0.168 0
      더보기

      이 자료와 함께 이용한 RISS 자료

      나만을 위한 추천자료

      해외이동버튼